aos
Publiée par EDP Santé
Open Access
Numéro
Actual. Odonto-Stomatol.
Numéro 248, Décembre 2009
Numéro spécial faculté d'odontologie de Nancy
Page(s) 369 - 379
Section Spécial Nancy
DOI https://doi.org/10.1051/aos/2009411
Publié en ligne 11 décembre 2009
  1. Elsuheibi ES, Zarb GA. Implant prosthodontics in medically challenged patients: the university of Toronto experience. J Can Dent Assoc 2002;68(2):103-108. [PubMed]
  2. Khavidi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with osseointegration surgery. J Prosthet Dent 1999;81(5):533-536. [CrossRef] [PubMed]
  3. Van Steenberghe D, Quirynen M, Molly L et al. Impact of systemic diseases and medication on osseointegration. Periodontol 2000 2003;33:163-171. [CrossRef] [PubMed]
  4. Alssadi G, Quirynen M, Komarek A et al. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 2007;34(7):610-617. [CrossRef] [PubMed]
  5. Alssadi G, Quirynen M, Michiles K et al. Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J Clin Periodontol 2008;35(1):51-57. [PubMed]
  6. Murrah A. Diabetes mellitus and associated oral manifestations: a review. J Oral Pathol 1985;14(4):271-81. [CrossRef]
  7. Reest D. Periodontal management of the patient with diabetes mellitus. Periodontol 2000;23:63-72. [CrossRef]
  8. Klokkevold P R. Periodontal medicine: assessment of risk factors for disease. J Can Dent Assoc 1999;27(2):135-42.
  9. Kopman JA, Kim DM, Rahman SS et al. Modulating the effects of diabetes on osseointegration with aminoguanadine and doxycycline. J Periodontol 2005;76(4):614-20. [CrossRef]
  10. Takeshita F, Iyama S, Ayukawa Y et al. The effects of diabetes on the interface between hydroxyapatite implants and bone in rats tibia. J Periodontol 1997;8(2):180-185. [CrossRef]
  11. Giannobile WV, Rios HF, Lang NP. Bone as a tissue. In: Clinical periondontology and implant dentistry. Oxford: Blackwell Munksgaard 2008:XX-1340-i26p.
  12. Olson JW, Shernoff AF, Tarlow JL et al. Dental endosseous implant assessment in a type 2 diabetic population: a retrospective study. J Oral Maxillofac Implants 2000;15(6):811-818.
  13. Peled M, Ardekian L, Tagger-Green N et al. Dental implants in patients with type 2 diabetes mellitus: a clinical study. Implant Dent 2003;12(2):116-22. [CrossRef] [PubMed]
  14. Bugea C, Luongo R, Di Lorio D et al. Contact os-implants ostéo-intégrés : analyse histologique d’un implant à la surface mordancée chez un patient diabétique. Parod Dent Restaur 2008;28:145-151.
  15. Paquette DW, Bordala N, Williams RC. Risks factors for endosseous dental implant failure. Dent Clin North Am 2006;50(3):361-374. [CrossRef] [PubMed]
  16. Chavanaz M. Patient screening and medical evaluation for implant and presprosthetic surgery. J Oral Implantol 1998;24(4):222-229. [CrossRef] [PubMed]
  17. Kleinfinger S, Goldberg M, Khayat P et al. Implantologie orale. Paris : Association dentaire française 2003:143 p.
  18. Bianchi A, Sanfilipo F. L’ostéoporose : effet sur la résorption de l’os maxillaire et options thérapeutiques implantaires. Parod Dent Restaur 2002;22:231-239.
  19. Roberts WE, Simmons KE, Garetto LP et al. Bone physiology and metabolism in dental implantology: risk factors for osteoporosis and other metabolic bone diseases. Implant Dent 1992;1(1):11-21. [CrossRef] [PubMed]
  20. Cho P, Scheinder GB, Krigan K. Examination of the bone interface in experimentally induced osteoporotic bone. Implant Dent 2000;13(1):79-87. [CrossRef]
  21. Sakakura CE, Giro G, Goncalves D et al. Radiographic assessment of bone density around integrated titanium implants after ovariectomy in rats. Clin Oral Implants Res 2006;17:134-138. [CrossRef] [PubMed]
  22. Duarte PM, Cesar JB, Goncalves PF et al. Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent 2003;12(4):340-6. [CrossRef] [PubMed]
  23. Pan J, Shirota T, Ohno K et al. Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite coated implants in the tibiae of mature rats. J Oral Maxillofac Surg 2000;58(8):877-882. [CrossRef] [PubMed]
  24. Sanfilipo F, Bianchi AE. L’ostéoporose : effet sur la résorption de l’os maxillaire et options thérapeutiques implantaires ; revue de la littérature et considérations cliniques. Parod Dent Restaur 2003;23:447-57.
  25. Sugerman PB, Barber MT. Patient selection for endosseous dental implants: oral and systemic considerations. J Oral Maxillofac Surg 2002;17(2):191-201.
  26. Herrmann J, Lekholm U, Holm S et al. Evaluation of patient and implant characteristics as potential prognostic factors for oral implant failures. Int J Oral Maxillofac Implants 2005;20(2):220-30. [PubMed]
  27. Hwang D, Wang H-L. Medical contraindications to implant therapy: part II: relative contraindications. Implant Dent 2007;16(1):13-23. [CrossRef] [PubMed]
  28. Friberg B, Ekestubbe A, Mellstrom D et al. Bränemark implants and osteoporosis: a clinical exploratory study. Clin Implant Dent Relat Res 2001;3(1): 50-66. [CrossRef] [PubMed]
  29. Grant B-T, Amenedo C, Freeman K et al. Outcomes of placing dental implants in patients taking oral biphosphonates: a review of 115 cases. J Oral Maxillofac Surg 2008;66(2):223-30. [CrossRef] [PubMed]
  30. Eberhardt C, Schwarz M, Brahnkamp J et al. Ibandronate improves osseointegration of cementless metal implants to a similar extent either given continously. Bone 2006;38:S48.
  31. Kurth AH, Eberhardt C, Müller S et al. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone 2005;37(2):204-210. [CrossRef] [PubMed]
  32. Frenkel SR, Jaffe WL, Valle CD et al. The effect of alendroante (fosamax) and implant surface on bone integration and remodeling in a canine model. J Biomed Mater Rest 2001;58(6):645-650. [CrossRef]
  33. Giro G, Goncalves D, Sakakura CE et al. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(2):162-7. [CrossRef] [PubMed]
  34. Giro G, Sakakura CE, Goncalves D et al. Effect of 17β oestradiol and alendronate on the removal torque of osseointegrated titanium implants in ovariectomized rats. J Periodontol 2007;78(7):1316-1321. [CrossRef]
  35. Wang HL, Weber D, Mc Cauley LK. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontol 2007;78(3):584-94. [CrossRef] [PubMed]
  36. Duarte PM, de Vasconcelos Gurgel BC, Sallum AW et al. Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol 2005;76(1):107-114. [CrossRef]
  37. Scully C, Madrid C, Bagan J. Dental endosseous implants in patients on biphosphonate therapy. Implant Dent 2006;15(3):212-218. [CrossRef] [PubMed]
  38. Addad H, Mas R. Biochimie Clinique. Paris : Vernazobres-Grego 2007;1vol:280p.
  39. Karr RA, Kramer DC, Toth BB. Dental implants and chemotherapy complications. J Prosthet Dent 1992;67(5):683-687. [CrossRef] [PubMed]
  40. Kovacs AF. Influence of chemotherapy on endosteal implant survival and success in oral cancer patients. Int J Oral Maxillofac Surg 2001;30(2):144-7 [CrossRef] [PubMed]
  41. Etienne D, Sanz M, Aroca S et al. Identification des patients à risque en implantologie orale (II). J Parodontol Implantol Orale 1998;17(3)98:273-297.
  42. Harrison WJ, Lewis CP, Lavy CB. Wound healing after implant surgery in HIV-positive patients. J Bone Joint Surg Br 2002;84(6): 802-806. [CrossRef] [PubMed]
  43. Achong RM, Shetty K, Arribas A et al. Implants in HIV-positive patients: 3 case reports. J Oral Maxillofac Surg 2006;64(8):1199-1203. [CrossRef] [PubMed]
  44. Ferreira SD, Silva GL, Cortelli JR et al. Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol 2006;33(12):929-935. [CrossRef] [PubMed]
  45. Beikler T, Flemming TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003;14(4):305-316. [CrossRef] [PubMed]
  46. Ulbro C, Crossner CG, Lundgren T et al. Osseointegrated implants in a patient with Papillon-Lefèvre Syndrome. A 4 1/2 year follow-up. J Clin Periodontol 2000;27(12):951-954. [CrossRef]
  47. Woo I, Brunner DP, Yamashita DR et al. Dental implants in a young patient with Papillon-Lefevre Syndrome: a case report. Implant Dent 2003;12(2):140-144. [CrossRef] [PubMed]
  48. Hodgson TA, Lewis N, Darbar U et al. The short-term efficacy of osseointegrated implants in patients with non-malignant oral mucosal disease: a case series. Oral Diseases 2006;12(s1):11. [CrossRef]
  49. Oczakir C, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care patients: a case series study. Int J Prosthodont 2005;18(5):383-389. [PubMed]
  50. Lustig JP, Yanko R, Ziberman U. Use of dental implants in patients with Down syndrome: a case report. Spec Care Dentist 2002;22(5):201-204. [CrossRef] [PubMed]
  51. Duarte PM, Noqueira Filho GR, Sallun EA et al. The effect of an immunosuppressive therapy and its with drawal on bone healing around titanium implants: a histomorphometric study in rabbits. J Periodontol 200;72(10):1391-7.
  52. Sakakura CE, Margonar R, Holzhausen M et al. Influence of cyclosporine. A therapy on bone healing around titanium implants: a histomorphometric and biomechanic study in rabbits. J Periodontol 2003;74(7):976-981.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.